Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_assertion type Assertion NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_head.
- NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_provenance.
- NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_assertion evidence source_evidence_literature NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_provenance.
- NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_assertion SIO_000772 9354682 NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_provenance.
- NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_assertion wasDerivedFrom befree-20150227 NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_provenance.
- NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_assertion wasGeneratedBy ECO_0000203 NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_provenance.